Daito Pharmaceutical Co (TSE:4577) Accounts Payable & Accrued Expense : 円6,790 Mil (As of Feb. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Daito Pharmaceutical Co Accounts Payable & Accrued Expense?

Daito Pharmaceutical Co's quarterly accounts payable & accrued expense increased from Aug. 2023 (円5,770 Mil) to Nov. 2023 (円7,345 Mil) but then declined from Nov. 2023 (円7,345 Mil) to Feb. 2024 (円6,790 Mil).

Daito Pharmaceutical Co's annual accounts payable & accrued expense increased from May. 2021 (円6,923 Mil) to May. 2022 (円7,812 Mil) and increased from May. 2022 (円7,812 Mil) to May. 2023 (円8,723 Mil).

Daito Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Daito Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daito Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Daito Pharmaceutical Co Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

5,499.83

7,854.13

6,923.00

7,812.00

8,723.00

Daito Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															5,894.00	8,723.00	5,770.00	7,345.00	6,790.00

Daito Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Daito Pharmaceutical Co (TSE:4577) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

326 Yokamachi, Toyama, JPN, 939-8567

Website

http://www.daitonet.co.jp

Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Daito Pharmaceutical Co (TSE:4577) Headlines

No Headlines